New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
Alexia Alexandraki(Bank of Cyprus Oncology Center), Anastasia Constantinidou(University of Cyprus), Kostas Marias(Hellenic Mediterranean University), Georgios C. Manikis(Foundation for Research and Technology Hellas), Davide Mauri(University Hospital of Ioannina), Gerasimos Filippatos(National and Kapodistrian University of Athens), Katerina Κ. Naka(University of Ioannina), Marina Zacharia(Bank of Cyprus Oncology Center), Maria Daniel(Bank of Cyprus Oncology Center), Cameron Brown, Dimitrios I. Fotiadis(University of Ioannina), Ifigenia Konstantinou(Bank of Cyprus Oncology Center), Effrosyni Kampouroglou(National and Kapodistrian University of Athens), Dorothea Tsekoura(National and Kapodistrian University of Athens), Yiola Marcou(Bank of Cyprus Oncology Center), Eleni Kakouri(Bank of Cyprus Oncology Center), Ketti Mazzocco(University of Milan), Άθως Αντωνιάδης, Domen Ribnikar(University of Ljubljana), Elisavet Papageorgiou(Bank of Cyprus Oncology Center), Manolis Tsiknakis(Hellenic Mediterranean University), Georgia S. Karanasiou(Foundation for Research and Technology Hellas), Kalliopi Keramida(National and Kapodistrian University of Athens), Myria Galazi(Bank of Cyprus Oncology Center), Carlo M. Cipolla(European Institute of Oncology), Andri Papakonstantinou(Karolinska University Hospital)
Cited by 17
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k